Cerebral activator
| Cerebral activator | |
|---|---|
| Drug class | |
| Class identifiers | |
| Synonyms | Cerebral metabolic enhancer; Cerebral metabolic activator; Cerebral metabolism activator; Cerebral metabolism enhancer |
| Use | To treat cerebrovascular diseases |
| Mode of action | Increase activation of the brain |
| Legal status | |
| In Wikidata | |
A cerebral activator, also known as a cerebral metabolic enhancer or activator, is a type of drug that "activates" the central nervous system in the context of cerebrovascular diseases such as stroke and dementia. The term has been used specifically to describe a few Japanese drugs, such as indeloxazine and bifemelane.[1][2][3]
See also
[edit]References
[edit]- ^ Yamamoto M, Kawabata S, Shimizu M (1989). "Pharmacological effects of indeloxazine, a new cerebral activator, on brain functions distinct from other cerebral metabolic enhancers". Neuropharmacology. 28 (12): 1291–1297. doi:10.1016/0028-3908(89)90001-4. ISSN 0028-3908. PMID 2615913. S2CID 10028363.
- ^ Takahashi K, Yamamoto M, Suzuki M, Ozawa Y, Yamaguchi T, Andoh H, Ishikawa K (1995). "Effects of cerebral metabolic enhancers on brain function in rodents". Current Therapeutic Research. 56 (5): 478–485. doi:10.1016/0011-393X(95)85080-5. ISSN 0011-393X.
- ^ van Reekum R, Black SE, Conn D, Clarke D (1997). "Cognition-enhancing drugs in dementia: a guide to the near future". Can J Psychiatry. 42 (Suppl 1): 35S–50S. PMID 9220128.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |